Pancreatic Cancer Research

ResearcherWesley HospitalActive in the last 2 years

Nicholas O’Rourke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0744-2816; OpenAlex author ID A5056858025. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  2. 68Ga-FAPI-46 PET/CT Versus 18F-FDG PET/CT for Pancreatic Cancer: A Feasibility Study. Co-author DOI 10.1111/1754-9485.70124↗
  3. Isolated abdominal wall recurrence of pancreatic ductal adenocarcinoma: a rare case report. Last author DOI 10.1093/jscr/rjae418↗
  4. Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study Co-author DOI 10.21203/rs.3.rs-1274952/v2↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Cavallucci · 2 shared papers, 2022–2026 · strength 0.46
  2. Tegan Lun · 1 shared paper, 2024 · strength 0.36
  3. Nicola Evans · 1 shared paper, 2026 · strength 0.32
  4. David Wong · 1 shared paper, 2026 · strength 0.32
  5. Elizabeth Stephanie Ahern · 1 shared paper, 2022 · strength 0.14
  6. Matthew Burge · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.